Seeing Is Believing
Healthcare - Sector
Chromadex Corp's activity chart (see below) currently has 56 price targets and 44 ratings on display.
Analysts average stock forecasts to be materialized ratio is 82.49% with an average time for these price targets to be met of 460.13 days.
Most recent stock forecast was given by from HC WAINWRIGHT on 17-Mar-2025. First documented stock forecast 03-Jan-2017.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2018
$11
$3.26 (42.12%)
$11
1 years 7 months 9 days ago
(17-Mar-2025)
13/16 (81.25%)
$3.06 (38.54%)
534
Buy Since 25-Sep-2017
$8.1
$0.36 (4.65%)
$12
1 years 7 months 21 days ago
(05-Mar-2025)
4/5 (80%)
$-0.45 (-5.26%)
590
Buy Since 09-Mar-2022
$8
$0.26 (3.36%)
$8
1 years 10 months 20 days ago
(06-Dec-2024)
5/5 (100%)
$1.28 (19.05%)
309
Hold Since 03-Nov-2022
$2
$-5.74 (-74.16%)
$2.1
3 years 7 months 17 days ago
(09-Mar-2023)
5/7 (71.43%)
$0.36 (21.95%)
591
$17
4 years 2 months 10 days ago
(16-Aug-2022)
2/3 (66.67%)
$5.25 (44.68%)
311
What is CDXC (Chromadex Corp) average time for price targets to be met?
Which analyst most recently updated their price target on CDXC (Chromadex Corp)?
Which analyst has the current lower performing score on CDXC (Chromadex Corp) with a proven track record?
Which analyst has the most public recommendations on CDXC (Chromadex Corp)?
Which analyst is the currently most bullish on CDXC (Chromadex Corp)?
Which analyst is the currently most reserved on CDXC (Chromadex Corp)?